Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Geoff Meacham ...
Zacks.com on MSN6d
NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to BuyNovo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...
Analyst recommends Novartis as a Buy for long-term investors, BioAge a Hold, following strategic partnership for age-related ...
Michael Ulz, an analyst from Morgan Stanley, maintained the Buy rating on Fractyl Health, Inc. (GUTS – Research Report). The associated price ...
Zacks.com on MSN6d
LLY Falls Around 14% in 3 Months: How to Play the StockEli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...
Eli Lilly (LLY) stock fell as its obesity therapy tirzepatide missed forecasts, amid focus on compounded weight loss ...
People are being “overdiagnosed” with obesity, leading medics have warned as they called for a “reframing” of the way the ...
As certain weight-loss drugs have become increasingly popular, scammers are taking notice and coming out of the woodwork to ...
The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...
On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through fully ...
Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback